BioCentury
ARTICLE | Clinical News

GlycoDesign, Leo Pharma preclinical data

December 16, 2002 8:00 AM UTC

In rabbit arterial and venous thrombosis prevention models, GH9001 showed better safety and efficacy than enoxaparin low molecular weight heparin and the thrombin inhibitor hirudin. The compound is in...